131030 — Optus Pharmaceutical Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapContrarian

Annual balance sheet for Optus Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	77,395	69,555	61,555	57,811	51,408
Net Total Accounts Receivable
Net Total Receivables	4,108	6,564	7,908	9,995	13,753
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	93,431	91,017	81,386	91,772	77,896
Net Property, Plant And Equipment	28,267	38,717	43,735	42,501	56,863
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	129,897	140,038	136,240	149,460	166,503
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	8,582	11,375	9,760	13,072	21,110
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	11,014	13,018	11,773	15,009	22,768
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	118,883	127,021	124,467	134,451	143,735
Total Liabilities & Shareholders' Equity	129,897	140,038	136,240	149,460	166,503
Total Common Shares Outstanding